Showing 14,621 - 14,640 results of 31,431 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (nn decrease)) ))', query time: 1.10s Refine Results
  1. 14621

    RNA degrades with time. by Jeffrey A. Blair (3178230)

    Published 2016
    “…(C) An antibody to rRNA shows a similar decrease of immunoreactivity with time, (D) but an antibody to dsDNA remains robust even after a PMI of 46 h. …”
  2. 14622

    Filamin mutants have less synchronous wing movements than control animals. by Lucas A. B. Fisher (18865005)

    Published 2024
    “…D) A 5-millisecond recording of a <i>filamin</i><sup><i>WT-GFP</i></sup> control fly. …”
  3. 14623

    Therapeutic efficacy study in <i>E</i>. <i>granulosus</i> infected mice. by Julia A. Loos (737868)

    Published 2017
    “…<p>(A) Box plots showing the comparative distribution of the weight (g) of cysts recovered from untreated mice (C) and treated with albendazole (ABZ, 5 mg/kg/d), metformin (Met, 50 mg/kg/d) and the combination of both drugs (ABZ+Met) for 60 days. …”
  4. 14624

    DataSheet_1_Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.docx by Yuwei Li (1612018)

    Published 2023
    “…When the vaccine price decreased by 60%, the ICER was reduced to 7,344.44 USD/QALY (4,392.89-10,309.23), indicating good cost-effectiveness taking China’s per capita GDP as a threshold.…”
  5. 14625

    Table_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).DOC by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  6. 14626

    Image_2_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  7. 14627

    Image_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  8. 14628
  9. 14629

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  10. 14630

    Data_Sheet_1_Soil Microbial Composition and phoD Gene Abundance Are Sensitive to Phosphorus Level in a Long-Term Wheat-Maize Crop System.doc by Ming Lang (3757117)

    Published 2021
    “…In the present study in the North China Plain, we subjected the bacterial and fungal communities to amplicon sequencing analysis and characterized the alkaline phosphatase gene (phoD) encoding bacterial alkaline phosphatase in a long-term field experiment (10 years) with six mineral P fertilization rates up to 200 kg P ha<sup>–1</sup>. …”
  11. 14631

    Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  12. 14632

    Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  13. 14633

    Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  14. 14634

    Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  15. 14635

    Image 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  16. 14636

    Image 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  17. 14637

    Image 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  18. 14638

    Targeting Ruminative Thinking in Adolescents at Risk for Depressive Relapse: Rumination-Focused Cognitive Behavior Therapy in a Pilot Randomized Controlled Trial with Resting State... by Rachel H. Jacobs (622107)

    Published 2016
    “…We also examined whether these changes in symptoms were associated with changes in functional connectivity of the posterior cingulate cortex (PCC), a key node in the default mode network (DMN). …”
  19. 14639

    Table 1_Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transpla... by Tatiana A. Rudakova (20945432)

    Published 2025
    “…Secondary endpoints included the cumulative incidence of a 25% decrease in serum lactate dehydrogenase levels and to the limit of the normal range for age from the date of the initiation of eculizumab, the cumulative incidence of a 50% increase in platelet count or stable platelet levels ≥ 20×10<sup>9</sup>/l was 74% (95% CI, 32–92) with median time 21 days (range: 1–104), cumulative incidence of platelet level ≥ 50×10<sup>9</sup>/l, and 1 year from the date of the initiation of eculizumab.…”
  20. 14640

    Data_Sheet_2_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”